Fed Circuit rejects Nobel Prize winner’s patent appeal
16-07-2020
CRISPR tech market to reach $1.72m by 2023: report
23-11-2018
superjoseph / Shutterstock.com
French microbiologist Emmanuelle Charpentier and US biochemist Jennifer Doudna have achieved scientific history by jointly winning the Nobel Prize in chemistry for their seminal work on gene-editing technology, CRISPR.
You need a subscription to continue reading this content.
Start a subscription today to access the LSIPR website.
To access the full archive, digital magazines and special reports you will need to take out a paid subscription.
If you have already subscribed please login.
If you have any technical issues please email tech support.
For access to the complete website, archive, and to receive print publications, choose '12 MONTH SUBSCRIPTION'. For a free, two-week trial with full access, select ‘TWO WEEK FREE TRIAL’.
Nobel prize, CRISPR, Emmanuelle Charpentier, Jennifer Doudna, University of California, ERS Genomics
